Glytec, LLC develops glycemic management solutions for diabetes patients worldwide. It offers glycemic management systems for dosage recommendations of insulin, glucose, and saline in appropriate environments. The company offers its products to stabilize excursions and maintain glucose levels within a target range utilizing guardrails that allow patients to achieve normoglycemia while minimizing the risk of cerebral edema, hypoglycemia, cardiac arrest, diabetes ketoacidosis, and neurological trauma. Its systems can be installed locally or operated remotely, including across the Internet. The company was incorporated in 2008 and is based in Greenville, South Carolina. Glytec, LLC operates as ...
665 North Academy Street
Greenville, SC 29601
Founded in 2008
13 Additional Health Systems Across the U.S. Selects Glytec's Eglycemic Management System
Jun 4 15
Glytec announced 13 additional health systems across the U.S. have recently selected the company’s eGlycemic Management System (eGMS). Collectively, they represent 37 new hospital implementations. eGMS enables providers, payers, and patients to control glucose levels, and combat the well-documented, spiraling complications and costs associated with diabetes and hyperglycemia. Glytec’s unique eGMS allows providers to embed evidence-based, medical intelligence in the patient care process for those in need of insulin therapy. eGMS provides clinician-developed, algorithm-based software (Glucommander) designed to consider insulin sensitivity and individualize dosing recommendations to address and prevent excursions through all aspects of insulin therapy – including intravenous (IV), transition from IV to subcutaneous (SubQ), SubQ, and pediatric dosing recommendations. The on-going performance and impact of the glycemic control initiative is measured and monitored through Glytec’s GlucoMetrics, a wide array of preset and/or on-demand clinical and business intelligence reports. Additionally, GlucoSurveillance provides real-time capabilities to proactively identify patients who will benefit from glycemic intervention and insulin therapy. eGMS is proven to achieve significantly better control than traditional, manual methods, while simultaneously rendering dangerous hypoglycemic events rare. eGMS facilitates a comprehensive, systems approach to diabetes management, beginning with seamless integration with the EHR. Through the standardization of processes and personalization of treatment, eGMS is proven to reduce infection rates, length-of-stay, readmissions and resource utilization (clinician time as well as supplies).